Dihydroergotamine nasal spray in the treatment of acute migraine

Headache

Volumn 38, Issue 8, 1998, Pages 614-617

  Treves, Therese A ^a   Kuritzky, Arieh ^b   Hering, Rachel ^b   Korczyn, Amos D ^a,b  

^a Tel Aviv Souraski Medical Center   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Dihydroergotamine (DHE); Headache treatment; Migraine

Indexed keywords

DIHYDROERGOTAMINE; NOSE SPRAY; PLACEBO; SUMATRIPTAN;

ADULT; ANALYTIC METHOD; ARTICLE; BIOAVAILABILITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; INTRANASAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MIGRAINE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0031756771     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.1998.3808614.x     Document Type: Article

References (14)

1. Nikiforow R, Hokkanen E. An epidemiological study of headache in an urban and a rural population in northern Finland. Headache. 1978;18:137-145.
2. Waters WE. Community studies of the prevalence of headache. Headache. 1970;9:178-186.
3. Bruyn GW. Epidemiology of migraine 'personal view.' Headache. 1983;23:127-133.
4. Cady RK, Wendt JK, Kirchner JR, Sargent JD, Rothrock JF, Skaggs H Jr. Treatment of acute migraine with subcutaneous sumatriptan. JAMA. 1991;265:2831-2835.
5. The Sumatriptan Auto-Injector Study Group. Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device. Eur Neurol. 1991;31:323-331.
6. Callaham M, Raskin N. A controlled study of dihydroergotamine in the treatment of acute migraine headache. Headache. 1986;26:168-171.
7. Tfelt-Hansen P, Ibraheem JJ, Paalzow L. Clinical pharmacology of ergotamine studied with a high-performance liquid chromatographic method. In: Rose FC, ed. Advances in Migraine Research and Therapy. New York: Raven Press; 1982:173-179.
8. Lataste X, Taylor P, Notter M. DHE Nasal Spray in the acute management of migraine attacks. Cephalalgia. 1989;9(suppl 10):342-343. Abstract.
9. Ziegler D, Ford R, Kriegler J, et al. Dihydroergotamine nasal spray for the acute treatment of migraine. Neurology. 1994;44:447-453.
10. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988;8(suppl 7):10-73.
11. Selby G, Lance JW. Observations on 500 cases of migraine and allied vascular headache. J Neurol Neurosurg Psychiatry. 1960;23:23-32.
12. Saper JR, ed. Treatment of migraine. In: Headache Disorders. Current Concepts and Treatment Strategies. Boston: John Wright-PSG Inc; 1983:61-86.
13. Hirt D, Lataste X, Taylor P. A comparison of DHE Nasal Spray and Cafergot in acute migraine. Cephalalgia. 1989;9(suppl 10):410-411. Abstract.
14. Scott AK. Dihydroergotamine: a review of its use in the treatment of migraine and other headaches. Clin Neuropharmacol. 1992;15:289-296.